Citations - Hoskin Peter

As patients live longer with their cancer as a result of more effective treatment, recurrences and second malignancies in a previously irradiated field are an increasing challenge. The technical advances that enable high-dose radiation to limited volumes, excluding critical normal tissues, have increased the use of re-irradiation for many tumour... Read more
Published on: 2020-09-07
Source: Hoskin Peter
By: S Armstrong
As patients live longer with their cancer as a result of more effective treatment, recurrences and second malignancies in a previously irradiated field are an increasing challenge. The technical advances that enable high-dose radiation to limited volumes, excluding critical normal tissues, have increased the use of re-irradiation for many tumour... Read more
Published on: 2020-09-07
Source: Hoskin Peter
By: S Armstrong
As patients live longer with their cancer as a result of more effective treatment, recurrences and second malignancies in a previously irradiated field are an increasing challenge. The technical advances that enable high-dose radiation to limited volumes, excluding critical normal tissues, have increased the use of re-irradiation for many tumour... Read more
Published on: 2020-09-07
Source: Hoskin Peter
By: S Armstrong
As patients live longer with their cancer as a result of more effective treatment, recurrences and second malignancies in a previously irradiated field are an increasing challenge. The technical advances that enable high-dose radiation to limited volumes, excluding critical normal tissues, have increased the use of re-irradiation for many tumour... Read more
Published on: 2020-09-07
Source: Hoskin Peter
By: S Armstrong
As patients live longer with their cancer as a result of more effective treatment, recurrences and second malignancies in a previously irradiated field are an increasing challenge. The technical advances that enable high-dose radiation to limited volumes, excluding critical normal tissues, have increased the use of re-irradiation for many tumour... Read more
Published on: 2020-09-07
Source: Hoskin Peter
By: S Armstrong
As patients live longer with their cancer as a result of more effective treatment, recurrences and second malignancies in a previously irradiated field are an increasing challenge. The technical advances that enable high-dose radiation to limited volumes, excluding critical normal tissues, have increased the use of re-irradiation for many tumour... Read more
Published on: 2020-09-07
Source: Hoskin Peter
By: S Armstrong
No abstract... Read more
Published on: 2020-09-05
Source: Hoskin Peter
By: Charlotte Elizabeth Coles
CONCLUSION: Within this large cohort of LACC survivors, a subgroup of patients with persistent symptoms (LAPERS events) was identified. For symptoms with corresponding EORTC/CTCAE assessment, the vast majority of LAPERS events occurred in patients without corresponding severe physician-assessed morbidity. These findings emphasize the importance of distinguishing between transient and persisting... Read more
Published on: 2020-08-28
Source: Hoskin Peter
By: Anders S Vittrup
CONCLUSIONS: A large number of publications recommended hypofractionated radiation therapy schedules across numerous major disease sites during the COVID-19 pandemic, which were supported by a lower quality of evidence than the highest-quality routinely used dose fractionation schedules. This work provides an evidence-based assessment of these potentially practice-changing recommendations and informs... Read more
Published on: 2020-08-17
Source: Hoskin Peter
By: David J Thomson
CONCLUSIONS: MRI and clinical examination resulted in a different local tumour staging in approximately one quarter of patients. Comprehensive knowledge of the differential value of clinical examination and MRI is necessary to define one final local stage, especially when a decision about treatment options is to be taken. The use... Read more
Published on: 2020-08-17
Source: Hoskin Peter
By: J Knoth
CONCLUSION: An empty bladder filling protocol has non-inferior bPFS, GI and GU toxicities at 4 years in patients with localised prostate cancer using advanced RT techniques in comparison to a full bladder filling protocol. A longer follow up with a larger sample size is required to validate this approach.... Read more
Published on: 2020-07-25
Source: Hoskin Peter
By: Gayan Chetiyawardana

Other Resources

Other Citations

Other Citations

News by Specialization

News by Specialization

Videos

Selection of Videos by Specialization

Latest News

Latest News

Translate »